Search for: "Abbott Laboratories, Inc."
Results 221 - 240
of 407
Sorted by Relevance
|
Sort by Date
14 Jul 2010, 6:47 pm
Anika Therapeutics, Inc. [read post]
19 Sep 2014, 3:00 am
The Eighth Circuit found that the dicta In re Abbott Laboratories, Inc., 698 F.3d 568 (7th Cir. 2012) applied to this case. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
22 Apr 2013, 2:43 pm
Abbott Laboratories Inc. agreed to pay $1.5 billion in order to resolve criminal and civil allegations surrounding the company’s off-label marketing of Depakote. [read post]
9 Sep 2009, 7:14 am
– Dispute between Wyeth and Dexel (The IP Factor) EpiPen (Epinephrine) – US: King Pharmaceuticals, Meridian Medical Technology file patent infringement suit against Teva following Para IV certification (Patent Docs) Seroxat (Paroxetine) – Israel: not even sublime, just ridiculous – Israel PTO decision in Unipharm v SmithKline Beecham (America-Israel Patent Law) Stelara (Ustekinumab, anti-IL-12 antibody) – Centocor seeks review of BPAI decision… [read post]
19 May 2010, 6:15 am
(Patent Docs) US: CAFC affirms claim construction and corresponding summary judgment of non-infringement: Scantibodies Laboratory, Inc. v. [read post]
14 Jul 2010, 11:55 am
. * * * * Advanced Magnetic Closures, Inc. v. [read post]
5 Aug 2014, 9:09 am
Studies Indicate Health Risks from Testosterone Therapy AndroGel is a topical testosterone-replacement medication produced and marketed by Abbott Laboratories and its AbbVie Inc. subsidiary. [read post]
13 Jan 2009, 2:19 pm
Abbott Laboratories, Inc., No. 06-55687 (9th Cir. [read post]
4 Jun 2008, 8:32 pm
TNF blockers currently approved for pediatric use include etanercept (Enbrel, Immunex Corp, marketed by Amgen and Wyeth Pharmaceuticals), adalimumab (Humira, Abbott Laboratories), and infliximab (Remicade, Centocor, Inc). [read post]
20 Oct 2010, 5:41 am
" The suit, filed against Abbott Laboratories Inc., comes after a September 22, 2010 recall "following two reports from consumers of beetle larvae in the formula. [read post]
20 Oct 2010, 5:41 am
" The suit, filed against Abbott Laboratories Inc., comes after a September 22, 2010 recall "following two reports from consumers of beetle larvae in the formula. [read post]
3 Sep 2009, 6:44 pm
Abbott Laboratories, 297 F.3d 544 (7th Cir. 2002); United States v. [read post]
2 May 2014, 10:23 am
Despite Auxilium Pharmaceuticals’ opposition, a joint response filed on behalf of other testosterone drug manufactures such as Abb Vie, Inc., Abbott Laboratories, Eli Lilly and Co., Lilly USA, LLC, and Endo Pharmaceuticals, Inc. indicates support for the centralization of all pending testosterone replacement therapy lawsuits before the same judge. [read post]
19 Mar 2012, 8:32 am
Abbott Laboratories, Inc., 2012 WL 764199 (E.D.N.Y.) [read post]
7 Nov 2008, 3:42 am
No problem: In re Ciprofloxacin Hydrochloride Antitrust Litigation (Patent Baristas) US: FTC Commissioner speaks out on follow-on biologics – current initiatives and long-term goals (FDA Law Blog) US: Hatch-Waxman Act-related lawsuits likely to drop, but generic companies may start to challenge biotechnology patents, says David Pritikin (Law360) US: Sequenom sues rival genetic research company Ibis Biosciences alleging infringement of DNA analysis patents (Law360) Products… [read post]
29 Jun 2009, 2:59 pm
Docket: 08-645 Title: Abbott v. [read post]
16 Aug 2018, 6:38 pm
.,551 F.2d 213, 219 (8th Cir. 1997))).(...)We ruled in Abbott Laboratories v. [read post]
27 Aug 2009, 7:43 am
Abbott Labs. v. [read post]
14 May 2012, 9:29 pm
--Townsend v Benjamin Enterprises, Inc, Case Nos. [read post]
